Q4 2021 in brief •Net sales increased 23% to EUR 999 million (EUR 813 million) •Adjusted EBIT was EUR 82 million (EUR 73 million); reported EBIT was EUR 84 million (EUR 48 million) •Adjusted EPS was EUR 0.54 (EUR 0.48); reported EPS was EUR 0.56 (EUR 0.30) •Comparable net sales growth was 12% at Group level and 19% in emerging markets •The impact of currency movements was EUR 24 million on the Group’s net sales and EUR 2 million on EBIT. Q1-Q4 2021 in brief •Net sales increased 8% to EUR 3,575 million (EUR 3,302 million) •Adjusted EBIT was EUR 315 million (EUR 302 million); reported EBIT was EUR 296 million (EUR 265 million) •Adjusted EPS was EUR 2.07 (EUR 1.95); reported EPS was EUR 1.91 (EUR 1.69) •Comparable net sales growth was 7% at Group level and 13% in emerging markets •The impact of currency movements was EUR -54 million on the Group’s net sales and EUR -6 million on EBIT •Capital expenditure was EUR 259 million (EUR 223 million) •Free cash flow was EUR -26 million (EUR 207 million)

Cascades announces an important repositioning of its Tissue Papers platform to enhance the performance of the business. The Company will simplify operations by concentrating the majority of its tissue product operating activities at core, geographically well-positioned sites that offer opportunities for future development. These changes will reduce costs, create synergies and significantly improve the Tissue Group’s financial, operational and environmental performance. This decision will not affect the level of service Cascades provides to its customers. Beginning in July 2023, Cascades will progressively close its underperforming plants in Barnwell, South Carolina, and Scappoose, Oregon, as well as the virgin paper tissue machine at its St. Helens plant, also in Oregon. The equipment slated for closure, which have a combined total annual rated capacity of 92,000 short tons of tissue paper and 10 million cases of converted product, have been operating below capacity producing 56,000 short tons of tissue paper and 5 million cases of converted product in 2022, mostly on the West coast. A portion of this production will be absorbed by open capacity at our other facilities and by the increase in productivity at our sites, particularly in the United States. Cascades has the option to evaluate the possibility of redeploying the seven conversion lines impacted by this decision to other sites at a later date.

Crown Holdings, Inc.’s Spartanburg, South Carolina, aerosol plant is set to offset one-third of its annual electrical usage by implementing a new solar panel array, covering approximately five acres. The project marks Crown’s first use of solar power energy worldwide and contributes to one of the Company’s 2020 sustainability goals of reducing its energy consumption by implementing renewable and alternative energy projects at the local level. “Crown’s mission is to continue identifying unique sustainability projects that align with our commitment to manage and conserve resources and bring innovations to market that support the sustainability efforts of our customers and consumers,” said John Rost, Director of Sustainability and Regulatory Affairs, Crown Holdings, Inc. “Working with Keystone Power Holdings to enact a project of this scale is a prime example of this effort in action. This project also contributes to Crown’s wider goal of continuing to drive down its emissions.” Click Read More below for additional information.